ACADIA Pharmaceuticals, Inc. (ACAD)
22.16
-0.24
(-1.07%)
USD |
NASDAQ |
Mar 06, 16:00
22.17
+0.01
(+0.05%)
After-Hours: 20:00
ACADIA Pharmaceuticals Market Cap : 3.778B for March 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insmed, Inc. | 30.21B |
| Madrigal Pharmaceuticals, Inc. | 9.830B |
| Marker Therapeutics, Inc. | 23.01M |
| Agilent Technologies, Inc. | 32.52B |
| BioMarin Pharmaceutical, Inc. | 11.75B |
Market Cap Related Metrics
| PE Ratio | 9.684 |
| PS Ratio | 3.507 |
| PEG Ratio | 0.1418 |
| Price to Book Value | 3.078 |
| Price to Free Cash Flow | 595.77 |
| Price | 22.16 |
| Earnings Yield | 10.33% |
| PEGY Ratio | 0.1418 |
| Operating PE Ratio | 35.86 |
| Normalized PE Ratio | 9.684 |